Aggressive Multimodality Therapy for Patients with Locally Advanced Esophageal Cancer: Is There a Role for Amifostine?

Seminars in Oncology

Volumn 30, Issue 6 SUPPL. 18, 2003, Pages 72-75

  Jatoi, Aminah ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ANEMIA; ARTHRALGIA; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; ESOPHAGITIS; ESOPHAGUS CANCER; FATIGUE; FEBRILE NEUTROPENIA; HUMAN; LEUKOPENIA; MULTIMODALITY CANCER THERAPY; MUSCLE WEAKNESS; MYALGIA; NAUSEA AND VOMITING; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 1642558239     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2003.11.013     Document Type: Conference Paper

References (18)

1. Hulscher JB, van Sandick JW, deBoer AG, et al: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669, 2002
2. Wobst A, Audisio RA, Collconi M, et al: Oesophageal cancer treatment: Studies, strategies, facts. Ann Oncol 9:931-942, 1998
3. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer. JAMA 281: 1623-1627, 1999
4. MacDonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-30, 2001
5. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
6. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538-543, 2003
7. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 359:1727-1733, 2002
8. Kelsen DP, Ginsberg R, Pajak TF, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998
9. Meluch AA, Hainsworth JD, Gray JR, et al: Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: Preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J 5:84-91, 1999
10. Meluch AA, Greco FA, Burris JR, et al: Preoperative paclitaxel, carboplatin, 5-FU and radiation therapy for localized esophageal cancer: Final results of a Minnie Pearl Cancer Research Network phase II trial. Proc Am Soc Clin Oncol 20:636A, 2001 (abstr)
11. Zemanova M, Pazdro A, Novak F, et al: Neoadjuvant chemotherapy with paclitaxel, carboplatin, 5-fluorouracil with consecutive surgery in esophageal cancer. Ann Oncol 13:188, 2002 (suppl 5) (abstr)
12. Kleinberg L, Knisely JPS, Heitmiller R, et al: Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44 Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 56:328-334, 2003
13. Hu K, Ship JA, Harrison LB: Rationale for integrating high-dose-rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer. Semin Oncol 30:40-48, 2003 (suppl 18)
14. Ménard C, Camphausen K, Muanza T, et al: Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: Rationale and early results. Semin Oncol 30:63-67, 2003 (suppl 18)
15. Chao KSC, Ozyigit G, Thorsdat WL: Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine. Semin Oncol 30:101-108, 2003 (suppl 18)
16. Choi NH. Radioprotective effect of amifostine in radiation pneumonitis. Semin Oncol 30:10-17, 2003 (suppl 18)
17. Koukourakis MI, Kyrias G, Kakolyris S, et al: Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study. J Clin Oncol 18:2226-2233, 2000
18. Martenson JA, Jatoi A, Mahoney M, et al: Use carboplatin AUC=4, not AUC= 6 with carboplatin, 5-FU, paclitaxel, amifostine, and radiation for locally advanced esophageal cancer: Results of a planned interim toxicity analysis from the North Central Cancer Treatment Group. Proc Am Soc Clin Oncol 22:350, 2003 (abstr 1404)